Results 1 to 10 of about 820,695 (332)
Headache can be divided into primary headache and secondary headache. In primary headache the headache syndrome, i.e. the head pain and any associated features, are the disease process. In secondary headache the headache syndrome is a symptom of an underlying disorder.
Sharon K, Bal, Gary R, Hollingworth
+9 more sources
Prevalence of headache disorders in Norway: results from the population based PopHEAD study. [PDF]
Argren MB +7 more
europepmc +3 more sources
Background. Spontaneous intracranial hypotension (SIH) is a secondary headache that has been attributed to a cerebrospinal fluid (CSF) leak. It may resolve spontaneously or require conservative treatment.
Elham Jafari +2 more
doaj +1 more source
Background Monoclonal antibodies (mABs) targeting the calcitonin gene-related peptide (CGRP) pathway represent the first disease-specific preventive migraine therapy.
Bottiroli Sara +9 more
doaj +1 more source
Background Migraine can manifest with an episodic or a chronic pattern in a continuum of disease severity. Multiple factors are associated with the progression of the pattern from episodic to chronic.
Rosaria Greco +7 more
doaj +1 more source
The Temporal Associations of Neck Pain and Headache - Implications for the Diagnostic Approach to the Myofascial Involvement in Migraine. [PDF]
Börner-Schröder C +11 more
europepmc +2 more sources
Background Calcitonin gene-related peptide (CGRP) is involved in migraine pathophysiology and blood pressure regulation. Although clinical trials have established the cardio-cerebrovascular safety profile of anti-CGRP treatment, limited high-quality real-
Kaicheng Wang +6 more
doaj +1 more source
Introduction. Migraine is one of the most common disabling neurological disorders. Recently developed monoclonal antibodies to calcitonin gene-related peptide (CGRP) or its receptor are the first targeted medication for preventive therapy of both ...
N. V. Vashchenko +5 more
doaj +1 more source
The Greek Society of Migraine and Headache Patients (GSMHP), maintaining a strong commitment to research and information, conducted its second web-based online survey named "Migraine in Greece—2020", following its first one conducted in 2018.
Emmanouil V. Dermitzakis +5 more
doaj +1 more source
Calcitonin gene-related peptide causes migraine aura
Background Although the involvement of calcitonin gene-related peptide (CGRP) in migraines is well-established, its specific role in investigating the aura phase, which often precedes the headache, remains largely unexplored. This study aims to instigate
Haidar M. Al-Khazali +8 more
doaj +1 more source

